| 注册
首页|期刊导航|中国药物经济学|糖尿病性骨质疏松症中医药治疗研究进展

糖尿病性骨质疏松症中医药治疗研究进展

曲静 张东鹏

中国药物经济学2024,Vol.19Issue(8):117-121,5.
中国药物经济学2024,Vol.19Issue(8):117-121,5.DOI:10.12010/j.issn.1673-5846.2024.08.025

糖尿病性骨质疏松症中医药治疗研究进展

Research Progress in the Treatment of Diabetes Osteoporosis with Traditional Chinese Medicine

曲静 1张东鹏2

作者信息

  • 1. 甘肃中医药大学中医临床学院,兰州 730000
  • 2. 甘肃省中医院内分泌科,兰州 730050
  • 折叠

摘要

Abstract

As a common complication of diabetic patients,pain,spinal deformity and fragility fracture are the most important clinical signs,and the risk of bone mass loss and fracture is significantly increased.Western medicine treatment of DOP is mainly to control blood sugar and supplement calcium or vitamin D.However,due to its limited curative effect,it is still difficult to meet the clinical treatment needs,and patients urgently need more effective treatment methods.According to the theory of traditional Chinese medicine,DOP belongs to the category of"dissipating thirst combined with bone potence".Relevant clinical studies have proved that the treatment of DOP by traditional Chinese medicine can effectively relieve patients'pain and other discomfort symptoms and improve their quality of life.This paper reviews the cognition and treatment of DOP in TCM.

关键词

糖尿病性骨质疏松症/骨痿/中医药/综述

Key words

Diabetes osteoporosis/Bone flaccidity/Traditional Chinese medical science/Review

分类

医药卫生

引用本文复制引用

曲静,张东鹏..糖尿病性骨质疏松症中医药治疗研究进展[J].中国药物经济学,2024,19(8):117-121,5.

基金项目

国家中医优势专科建设项目(甘卫中医函[2023]63 号) (甘卫中医函[2023]63 号)

甘肃省科技厅重点研发项目(20YF8FA089) (20YF8FA089)

中国药物经济学

1673-5846

访问量0
|
下载量0
段落导航相关论文